49
Participants
Start Date
October 4, 2018
Primary Completion Date
July 8, 2023
Study Completion Date
September 18, 2026
Anetumab Ravtansine
Given IV
Laboratory Biomarker Analysis
Correlative studies
Pembrolizumab
Given IV
Pharmacological Study
Correlative studies
University of Pittsburgh Cancer Institute (UPCI), Pittsburgh
University of Maryland/Greenebaum Cancer Center, Baltimore
Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
Duke University Medical Center, Durham
University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
UM Sylvester Comprehensive Cancer Center at Coral Gables, Coral Gables
UM Sylvester Comprehensive Cancer Center at Kendall, Miami
UM Sylvester Comprehensive Cancer Center at Aventura, Aventura
UM Sylvester Comprehensive Cancer Center at Plantation, Plantation
UM Sylvester Comprehensive Cancer Center at Deerfield Beach, Deerfield Beach
University of Alabama at Birmingham Cancer Center, Birmingham
University of Kentucky/Markey Cancer Center, Lexington
Mayo Clinic in Rochester, Rochester
Northwestern University, Chicago
University of Chicago Comprehensive Cancer Center, Chicago
Washington University School of Medicine, St Louis
Siteman Cancer Center-South County, St Louis
Siteman Cancer Center at West County Hospital, Creve Coeur
Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
UT Southwestern/Simmons Cancer Center-Dallas, Dallas
UCHealth University of Colorado Hospital, Aurora
Huntsman Cancer Institute/University of Utah, Salt Lake City
Mayo Clinic Hospital in Arizona, Phoenix
Mayo Clinic in Arizona, Scottsdale
Los Angeles General Medical Center, Los Angeles
USC / Norris Comprehensive Cancer Center, Los Angeles
City of Hope Comprehensive Cancer Center, Duarte
UC San Diego Moores Cancer Center, La Jolla
USC Norris Oncology/Hematology-Newport Beach, Newport Beach
Mayo Clinic in Florida, Jacksonville
Massachusetts General Hospital Cancer Center, Boston
Dana-Farber Cancer Institute, Boston
University Health Network-Princess Margaret Hospital, Toronto
National Cancer Institute (NCI)
NIH